RNU6-980P

Across TCGA pan-cancer cohorts, RNU6-980P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-980P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-980P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-980P expression acts as an unfavorable survival marker, although some lineages such as ESCA and KIRP show a favorable association.

BLCA, UCEC, and KIRC are the cancer types where RNU6-980P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.096	0.594	<.001	90	view →
UCEC	OS	Tertile	All	0.803	0.931	<.001	84	view →
KIRC	DFS	Tertile	III,IV	0.167	0.744	<.001	36	view →
THCA	DFS	Tertile	II,III,IV	0.107	0.769	<.001	36	view →
ESCA	OS	Tertile	III,IV	1.000	0.359	.010	36	view →
LIHC	DFS	Tertile	All	0.097	0.543	.033	18	view →
TGCT	OS	Tertile	All	0.862	0.993	<.001	18	view →
LGG	DFS	Tertile	All	0.462	0.828	.002	9	view →
KIRP	DFS	Tertile	III,IV	1.000	0.309	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-980P–BLCA (OS)

Open the BLCA breakdown →